Sell side
-
How IR teams can master analyst consensus
Analyst consensus – the aggregated estimates from analysts on a company’s upcoming results – is a critical part of the financial communication landscape and an essential tool for IR teams. Yet for many investor relations professionals, working with analyst consensus is time-consuming, difficult to analyze and too often based on incomplete data.
-
Navigating market volatility: A data-centric approach
This year, market volatility has surged dramatically, fueled by dynamic US trade policies and ensuing responses from governments around the globe. The market landscape is shifting almost daily, leaving companies scrambling to provide clear forecasts amid a sea of uncertainty. Meanwhile sell-side analysts, traditionally reliant on stable, predictable data, now find themselves venturing into new data sources to recalibrate their projections on the fly.
-
How to leverage data to successfully navigate market expectations
A modern IR team needs a solid foundation of real-time analytics to confidently steer their organization through the turbulence of market expectations. High-quality data transforms challenges into opportunities, fostering a culture where every forecast is an informed step toward sustainable growth. This playbook, developed in partnership with Visible Alpha, now a part of S&P Global Market Intelligence, offers a comprehensive guide to mastering this critical aspect of navigating the capital markets.
-
‘I under-appreciated the work that went into IR’: What it’s really like to move from the sell side to investor relations
When asked for an example of a time she really leaned into her skills honed on the sell side, Bonita To, director of investor relations at First Quantum Minerals, points to a unique situation: the shutting down of one of the firm’s mines by the Panamanian government in November 2023. ‘The balance sheet became quite distressed and it was very apparent that we would need to take some action in terms of addressing our liquidity constraints – including going to the capital markets,’ she recalls.
-
Clear Street launches healthcare equity research, to debut at JP Morgan Healthcare conference
Financial technology and capital markets firm launched its healthcare and biotechnology equity research last month
-
Why liquidity deserves a spot on every issuer’s to-do list
When it comes to capital markets, liquidity is the quiet hero everyone needs but rarely talks about
-
Taking the Shein off: Human rights group petitions against London IPO
Analysts say listing unlikely to deliver wider appeal among Chinese companies – even if London can pull it off
-
Crafting clarity in investor relations
Data-centric approach crucial to coherent narrative
-
Best Practice Report: Enhance your sell-side engagement
Practical steps from leading IROs on effectively and efficiently networking with analysts and shareholders
-
Best Practice Report: How to engage with the sell side
Leading IROs on how they work with the sell side to achieve the biggest value for their IR programs
-
Filling the gap: What to know about paying for equity research
At around $45,000 a year, paid research isn’t cheap – but irlabs argues it’s worth the spend for companies lacking coverage
